At the last check on Friday, Vicarious Surgical Inc.’s (NYSE:RBOT) stock was up $0.05, moving up 6.06 percent to $0.94. The average number of shares traded per day over the past five days has been 910,485 shares. 3 times new highs have been achieved over the past 5 days. In the last twenty days, the average volume was 2,064,621, while in the previous 50 days, it was 1,017,216.
Since last month, RBOT stock retreated -52.50%. Shares of the company fell to $0.8200 on 08/08/23, the lowest level in the past month. A 52-week high of $4.57 was reached on 02/14/23 after having rallying from a 52-week low of $0.82. Since the beginning of this year, RBOT’s stock price has dropped by -53.44% or -$1.0900, and marked a new high 13 times. However, the stock has declined by -79.42% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
RBOT stock investors should be aware that Vicarious Surgical Inc. (RBOT) stock had its last reported insider trading activity 11 days ago on Aug 07. Khosla Ventures V, L.P., the 10% Owner of the company, purchased of 8,000,000 shares for $1.00 on Aug 07. It resulted in a $8,000,000 investment by the insider. Kelly William John sold 4,985 shares at an average price of $0.86 on Aug 07. The insider now owns 562,989 shares following the transaction. On Jul 05, CFO and Treasurer Kelly William John sold 4,859 shares at $1.83 apiece. The transaction was valued at $8,877.
Financial Health
In the three months ended June 29, Vicarious Surgical Inc.’s quick ratio stood at 11.40, while its current ratio was 11.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.19, and the total debt-to-equity ratio was 0.19. Based on annual data, RBOT earned $0.2 million in gross profit and brought in $80.08 million in revenue.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Vicarious Surgical Inc. to report -$0.14 quarterly earnings, the actual figure was -$0.12 per share, beating the consensus estimate by 14.30%. During the quarter, the company generated -$21.02 million in EBITDA. The liabilities of Vicarious Surgical Inc. were 28.84 million at the end of its most recent quarter ended June 29, and its total debt was $15.3 million. The value of shareholders’ equity is $127.3 million.
Technical Picture
This quick technical analysis looks at Vicarious Surgical Inc.’s (RBOT) price momentum. With a historical volatility rate of 273.93%, the RSI 9-day stood at 26.46% on 17 August.
At present, RBOT shares trade -54.19% below its 20-day simple moving average and -59.91% percent below its 100-day simple moving average. However, the stock is currently trading approximately -59.74% below its SMA50 and -75.97% below its SMA200.
Stochastic coefficient K was 9.29% and Stochastic coefficient D was 7.98%, while ATR was 0.0957. Given the Stochastic reading of 12.79% for the 14-day period, the RSI (14) reading has been calculated as 25.81%.
Analyst Ratings
Vicarious Surgical Inc. downgraded its rating on Vicarious Surgical Inc. (NYSE: RBOT) to a Neutral in a note to investors on March 04, 2022. The analysts firm previously had an Overweight rating on the stock.Vicarious Surgical Inc. (RBOT) has been rated Overweight by analysts. According to 0 brokerage firms, RBOT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Vicarious Surgical Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $7.50, the current consensus forecast for the stock is $4.00 – $9.00. Based on these forecasts, analysts predict Vicarious Surgical Inc. (RBOT) will achieve an average price target of $7.00.
